Engflag

Doxylamine

Quick links to important sections

Doxylamine

Doxylamine_DA

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doxylamine

What is Doxylamine? (Foundational Definition)

Property Description
Active ingredient Doxylamine succinate
Form Oral tablet, capsule, or liquid solution
Pharmacological class First-generation Antihistamine
Common use Short-term relief of occasional sleeplessness
Origin Synthetic compound (Ethanolamine derivative)

What Type of Medicine is Doxylamine? (Identity and Classification)

Doxylamine is a synthetic organic compound classified as a first-generation antihistamine, belonging to the ethanolamine chemical subclass. This medicine is primarily formulated as the stable salt, Doxylamine succinate, which serves as the active ingredient in various oral preparations. Unlike newer antihistamines, Doxylamine's chemical structure facilitates strong penetration into the central nervous system, which dictates its high potency and principal therapeutic application. This chemical structure accounts for the compound's potent sedative properties, separating it from newer non-sedating agents. This structural difference means the medicine is specifically designed to produce noticeable drowsiness. It is available both as a single-ingredient product, often positioned as an over-the-counter sleep aid, and in combination products alongside other active substances.

Is Doxylamine a Sleep Aid or an Allergy Medication? (Purpose and Form)

Doxylamine's primary general purpose is the short-term relief of occasional sleeplessness, but it is also used to address general allergic symptoms. Its pronounced effect on the central nervous system makes it a highly effective hypnotic agent. While the substance can diminish symptoms related to mild allergic reactions, its strong sedative property means it is most commonly sought for its use as a sleep aid. This recognized use as an over-the-counter aid confirms its primary role in addressing temporary difficulty falling asleep. The drug is administered via the oral route, typically supplied as an immediate or extended-release oral tablet or as an oral liquid solution, providing flexibility based on the desired onset and duration of effect.

How Does Doxylamine's Class Affect Its General Action? (High-Level Mechanism Concept)

Doxylamine's classification as a first-generation agent allows it to block the wakefulness signals in the brain, leading to a noticeable slowing of the central nervous system. This action, known as H₁ receptor blockade, directly creates a state of CNS depression that promotes drowsiness and facilitates sleep. This direct suppression of wakefulness, inherent to its chemical class, distinguishes its function and is the basis for its general therapeutic role as a potent sedative.

Regulatory References

  1. MedlinePlus - Doxylamine Use

What side effects are possible with Doxylamine?

Possible Side Effects and Safety Information

The safety profile for Doxylamine is organized by regulatory agencies around two primary domains: Central Nervous System (CNS) effects and Anticholinergic effects. Somnolence (drowsiness or sleepiness) is the most frequently documented adverse event, classified as Common (ge 1/100 to <1/10) in official regulatory documents. Other reactions classified as Common include dry mouth, fatigue, and dizziness.

Documented Adverse Reaction Categories

Adverse effects are categorized by System-Organ-Class in regulatory labeling, including:

System-Organ Class Examples of Documented Effects
Nervous System Somnolence, Dizziness, Headache
Gastrointestinal Dry mouth, Constipation, Abdominal pain
Eye/Urinary Blurred vision, Urinary retention

Population-Specific Safety Statements

Official documents note specific safety considerations for certain populations. Side effects related to anticholinergic activity, such as confusion, dry mouth, and constipation, may be more likely in older adults. For breastfeeding infants, the passage of the drug into breast milk is documented, with reports of sedation or irritability observed. Use in children under 12 years of age for short-term sleep relief is generally not recommended in regulatory guidance.

Safety Restrictions and Serious Reactions

Regulatory labeling establishes key safety constraints. Concomitant use with alcohol or other CNS depressants is restricted due to the potential for intensified drowsiness and severe impairment. Caution is also required in individuals with conditions sensitive to anticholinergic effects, such as narrow-angle glaucoma or urinary bladder-neck obstruction. While rare under therapeutic use, toxic doses are documented to be associated with severe outcomes, including seizures and acute renal failure.

Overdose and Emergency Response

Overdose of Doxylamine succinate is characterized by a dual pattern of effect on the central nervous system (CNS). Officially documented manifestations may include signs of CNS stimulation, such as tremors, nervousness, and hallucinations, which can progress to profound CNS depression, impaired consciousness, and ultimately coma. Significant anticholinergic toxicity is also documented, manifesting as fixed and dilated pupils (mydriasis), dry mouth, tachycardia, and urinary retention.

Regulatory documents highlight the potential for severe, life-threatening outcomes. These include grand mal seizures, potentially fatal cardiovascular reactions, and cardiopulmonary arrest, with children noted to be at a particularly high risk for the latter. Rhabdomyolysis leading to acute renal failure is also an officially recognized complication.

Due to the severity of these risks, regulatory agencies mandate that immediate action must be taken. The official guidance is to seek immediate medical help or contact a Poison Control Center right away. Emergency services must be called immediately if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Treatment primarily involves symptomatic and supportive medical care. Monitoring of vital signs and laboratory tests like creatine kinase is typically required. Physostigmine may be administered in severe cases to reverse central and peripheral anticholinergic effects.

Therapeutic Uses of Doxylamine

What Doxylamine Treats: Main Uses and Benefits

Doxylamine is relevant within therapeutic domains where additional symptomatic support is appropriate. The medication plays a role in managing symptoms that may become disruptive. In this capacity, the medication is used for the short-term treatment of insomnia and the relief of cold and allergy symptoms.

The medication is relevant for easing symptoms that interfere with daily functioning, including occasional sleeplessness, sleep initiation disturbances, and symptoms related to inflammatory or irritative states such as sneezing, runny nose, and itching. Doxylamine may be part of symptomatic management applied in addressing nausea and vomiting associated with pregnancy (NVP), relevant in clinical settings marked by increased discomfort.

It is often applied in scenarios where short-term symptomatic assistance is needed to help ease discomfort and assists with maintaining functional stability.

Quick Fact: Relief for Disruptive Sleep and Nausea Doxylamine supports patients during episodes of heightened discomfort by easing the overall symptom load across three therapeutic domains, helping to address sleep-related symptoms, NVP manifestations, and symptoms related to inflammatory or irritative states.

Regulatory References

  1. Doxylamine: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Doxylamine?

The eligibility for Doxylamine is defined by regulatory agencies based on age, pre-existing conditions, and concurrent medication use.

Category Regulatory Status (Official Labeling)
Absolute Contraindications Contraindicated for patients with known hypersensitivity to doxylamine or other ethanolamine derivative antihistamines.
Contraindicated in individuals concurrently taking Monoamine Oxidase Inhibitors (MAOIs).
Approved Age Groups The single-ingredient sleep aid is approved for adults and children 12 years of age and over.
For the Nausea and Vomiting of Pregnancy (NVP) indication, the combination product is approved for pregnant women ge 18 years.
Age Exclusion Safety and efficacy as a sleep aid is not established in children under 12 years of age.
Conditional Use/Caution Use with caution is required for patients with conditions potentially affected by anticholinergic properties, including narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal or bladder-neck obstruction, and asthma.
Pregnancy/Lactation Pregnancy: Intended for use in pregnant women for the NVP indication.
Lactation: Not recommended; a decision must be made to discontinue nursing or discontinue the drug, as Doxylamine is excreted into breast milk.

Regulatory documents emphasize that the medicine has not been studied in women with hyperemesis gravidarum, serving as a limitation on the NVP indication.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Doxylamine's regulatory interaction profile is defined primarily by its classification as a potent first-generation antihistamine, leading to officially documented pharmacodynamic and contraindication-related restrictions.

Formal Restrictions and Prohibitions

Interaction Type Interacting Substance/Class Official Regulatory Statement
Contraindicated Combination Monoamine Oxidase Inhibitors (MAOIs) Prohibited due to the risk of intensifying and prolonging the anticholinergic effects. A 14-day separation period following MAOI cessation is required.
Pharmacodynamic Additive Effect Central Nervous System (CNS) Depressants (e.g., sedatives, alcohol, certain opioid analgesics) Concurrent use is not recommended due to the high risk of additive CNS depression, potentially leading to severe drowsiness.
Toxicity Enhancement Anticholinergic Agents (e.g., tricyclic antidepressants, neuroleptics) May enhance toxicity due to the addition of anticholinergic effects.

Procedural and Metabolic Notes

Regulatory information notes that doxylamine may interfere with certain laboratory procedures, specifically causing false positive results in official urine screening tests for substances including opiates, methadone, and phencyclidine phosphate (PCP). Additionally, a precautionary avoidance recommendation exists for co-administration with Cytochrome P-450 (CYP) Inhibitors, based on the drug's metabolic pathway. Taking delayed-release formulations with food may delay the onset of action and potentially reduce absorption.

Mechanism of Action

Central Histamine H1 Receptor Blockade

Doxylamine functions by acting as a competitive antagonist at the Histamine H1 receptors ( HRH1) within the central nervous system (CNS). Due to its ability to rapidly cross the blood-brain barrier, it inhibits the binding of histamine, which is a primary excitatory neurotransmitter for alertness. This suppression of the histaminergic wakefulness pathway leads directly to generalized CNS depression.

Dual Antagonism and Vestibular Pathway Modulation

The molecule also exhibits a strong, non-selective antagonism at muscarinic acetylcholine receptors, classifying it as an anticholinergic agent. This dual H1 and muscarinic blockade affects the neural circuits involved in controlling balance and the emesis reflex. The consequence is a reduction in signaling within the vestibular system and the chemoreceptor trigger zone.

Mechanistic Limitation: Tolerance and Adaptation

The long-term effectiveness of the central H1 blockade is subject to biological constraints; repeated exposure can lead to desensitization or adaptive counter-mechanisms in the target receptors or neural circuits. This adaptation is a physiological constraint that ultimately results in a progressive reduction in the physiological response to the central antagonism over continuous administration.

Dosage and Administration Information

How Doxylamine is Used: Official Administration Guidelines

Official instructions for doxylamine succinate define its use by administration route, specific dosing schedules, and duration limits that vary by formulation. The medicine is exclusively approved for oral administration.

Dosing and Frequency

Indication Standard Adult Dosing (Monotherapy) Frequency & Timing
Occasional Sleeplessness 25 mg once daily Taken 30 minutes before retiring
NVP (Combination Product) Titrated, starting at 20 mg DS Scheduled daily use, up to four times daily

For the single-ingredient 25 mg product, use is generally limited to a short-term 2-week duration for self-medication. Pediatric use of the 25 mg tablet is not recommended for patients under 12 years of age.

Administration Conditions

Condition Instruction for Combination (NVP) Tablets
Food Intake Must be taken on an empty stomach with water.
Tablet Integrity Delayed-release and extended-release tablets must be swallowed whole and must not be crushed, chewed, or split to maintain their specialized release properties.

Treatment with the fixed-combination product for NVP begins with a bedtime dose and is titrated over several days, with a requirement that it be taken on a scheduled daily basis, not on an as-needed basis. Upon discontinuation of the NVP combination product, a gradual dose tapering is recommended.

Recent Clinical Evidence

Doxylamine: Recent Clinical Evidence

Clinical Context and Primary Indications

Doxylamine, an antihistamine belonging to the ethanolamine class, is primarily studied and used for its sedative properties. The most significant area of recent clinical focus for doxylamine is its use, in combination with pyridoxine (Vitamin B6), for the management of nausea and vomiting of pregnancy (NVP), commonly known as morning sickness. This combination therapy is the only medication approved by the U.S. Food and Drug Administration (FDA) for this specific indication.

Research Findings on Nausea and Vomiting of Pregnancy (NVP)

Controlled clinical trials evaluating the doxylamine-pyridoxine combination for NVP have consistently reported a statistically significant reduction in symptom severity compared to placebo. These studies track outcomes using established measurement scales, such as the Pregnancy-Unique Quantification of Emesis (PUQE) score.

Research indicates that the delayed-release formulation of the combination is designed to provide sustained action, helping to manage symptoms throughout the day and night. Studies report that common side effects observed are typically mild, with drowsiness being the most frequently noted adverse event attributable to the doxylamine component.

Other Uses and Supportive Evidence

Beyond NVP, doxylamine is also marketed as a short-term sleep aid. Its efficacy in this application is supported by its mechanism of action as a potent antagonist of H1 histamine receptors, which promotes sedation. Research in this area suggests that doxylamine may reduce sleep latency (the time it takes to fall asleep) and improve sleep quality scores in individuals experiencing temporary sleeplessness. However, its use is generally restricted to short durations to mitigate the risk of tolerance or dependence, and to limit daytime residual effects.

Key Studies & References

  1. ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy

Frequently Asked Questions (FAQ)

Common questions about Doxylamine (FAQ)

Q: What is doxylamine used for?

A: Doxylamine is an antihistamine used to treat the symptoms of the common cold, such as sneezing and a runny nose, and to relieve symptoms of allergies like hay fever (seasonal allergic rhinitis). It is also commonly used as a short-term aid for sleep (an occasional sleep aid).

Q: How quickly does doxylamine start to work?

A: When taken by mouth, doxylamine is typically absorbed quickly. Its effects for sleep are usually felt within 30 minutes to one hour. For allergy symptoms, relief can also occur within a similar timeframe, though the full effect may take slightly longer.

Q: Can doxylamine be taken during pregnancy?

A: Doxylamine, often in combination with pyridoxine (vitamin B6), is frequently used to treat nausea and vomiting of pregnancy (NVP), also known as morning sickness, when initial non-pharmacological methods have not been sufficient. When considering its use during pregnancy, it is important to follow the guidance of a healthcare provider.

Q: What are the most common side effects of doxylamine?

A: As a first-generation antihistamine, the most common side effect of doxylamine is drowsiness or sedation. Other common side effects may include dry mouth, dry eyes, blurred vision, constipation, and difficulty urinating.

Q: Can I drink alcohol while taking doxylamine?

A: No, you should avoid drinking alcohol while taking doxylamine. Both alcohol and doxylamine can cause drowsiness and central nervous system (CNS) depression. Combining them significantly increases the risk of excessive sedation, dizziness, impaired coordination, and difficulty performing tasks that require mental alertness.

Q: Is doxylamine habit-forming?

A: Doxylamine itself is not considered to be an addictive substance like some controlled medications. However, if used regularly for sleep, the body may become dependent on it to fall asleep, and stopping it suddenly might lead to temporary rebound insomnia (worsened difficulty sleeping). It is generally intended for short-term or occasional use.

Q: What should I do if I miss a dose?

A: Doxylamine is generally taken on an as-needed basis, especially when used for sleep or acute allergy symptoms.

  • If you miss a dose for sleep: Do not take the missed dose unless you can get a full night's sleep (usually 7-8 hours) afterward to avoid excessive drowsiness the next day.
  • If you are taking it regularly for a condition (like NVP) and miss a dose, take it as soon as you remember, but do not double the dose. Skip the missed dose if it is almost time for your next scheduled dose. Follow the dosing schedule provided by your healthcare provider.

Q: Does doxylamine interact with other medications?

A: Yes, doxylamine can interact with other medications, particularly those that also cause drowsiness or have anticholinergic effects. Key interactions include:

  • CNS depressants: Such as other sleep aids, tranquilizers, sedatives, narcotics, and certain antidepressants.
  • Other anticholinergic drugs: Such as some medications for overactive bladder, Parkinson's disease, or other older antihistamines.

These combinations can increase the risk of severe side effects like excessive sedation. Always inform your healthcare provider about all prescription and non-prescription medications, herbal supplements, and vitamins you are taking.

How should Doxylamine be stored and disposed of?

How to Store and Dispose of Doxylamine

The storage and disposal of Doxylamine products must strictly follow official regulatory guidelines to maintain potency and ensure safety.

Official Storage Requirements

Constraint Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C.
Environment Must be kept away from excess heat and moisture; do not store in the bathroom.
Container Keep in the tightly closed, original container and do not use if packaging is compromised.
Protection Mandatory to keep out of the sight and reach of children.

Official Disposal Procedures

Unused or expired Doxylamine should primarily be taken to a drug take-back location or mail-back program. If these are unavailable, the medication may be discarded in the household trash. This requires removing the medicine from its original container, mixing it with an undesirable substance (such as dirt or coffee grounds), and sealing the mixture in a plastic bag before disposal. Doxylamine must not be flushed down the toilet or sink, as it is not on the FDA's flush list for immediate environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Doxylamine found in:

A-Z Index: